Putnam BioRevolution ETF (SYNB) Research

This exchange-traded fund (ETF) primarily allocates its capital to common equity securities issued by companies globally, irrespective of their market capitalization. Its central investment theme revolves around enterprises driving the "biology revolution," whether they are classified as growth-oriented, value-based, or a blend of both. Periodically, the fund may dedicate a substantial segment of its assets to firms operating within one or more interconnected industries or sectors. These could encompass areas such as healthcare, consumer discretionary, consumer staples, biotechnology, and materials. As a non-diversified fund, its portfolio may exhibit higher concentration.

Market snapshot

Symbol
SYNB
Price
$31.61
Day change
-0.37%
Market cap
$5.3M
52-week range
24.573-31.728
Sector
Financial Services
Industry
Asset Management

Peer companies

  • Alger Weatherbie Enduring Growth ETF (AWEG)
  • Bitwise Web3 ETF (BWEB)
  • Macquarie Focused International Core ETF (EXUS)
  • Franklin Dividend Growth ETF (FRIZ)
  • Renaissance International IPO ETF (IPOS)
  • Pacer BlueStar Digital Entertainment ETF (ODDS)
  • Reverb ETF (RVRB)
  • Shelton Equity Premium Income ETF (SEPI)

Open Putnam BioRevolution ETF (SYNB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.